// company-profile
Olema Pharmaceuticals, Inc. Insider Trading
OLMAEvery SEC Form 4 insider trading filing for Olema Pharmaceuticals, Inc. (OLMA) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=OLMA" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
Recent insider activity is bearish. Over the last 30 days, insiders net sold $291K across 2 transactions.
// 90-day insight
Over the last 90 days, Olema Pharmaceuticals, Inc. insiders bought $0 (11 transactions) and sold $291K (2 transactions).
- Most active insider: Harmon Cyrus with 3 transactions totaling $291K.
- Largest single sale: $146K by Harmon Cyrus on Jul 24, 2026.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Olema Pharmaceuticals, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 24, 2026 | Harmon Cyrus | OLMA | Sale | 12,500 | $11.71 | $146K |
| Jul 23, 2026 | Harmon Cyrus | OLMA | Sale | 12,500 | $11.58 | $145K |
| Jun 18, 2026 | Garland J. Scott | OLMA | Award | 29,500 | $0.00 | $0K |
| Jun 18, 2026 | Hrustanovic Gorjan | OLMA | Award | 29,500 | $0.00 | $0K |
| Jun 18, 2026 | Graham G. Walmsley | OLMA | Award | 29,500 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →